Previous Article | Next Article 
Journal of Clinical Microbiology, August 1998, p. 2380-2382, Vol. 36, No. 8
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Purification of Encephalitozoon Cultures
Contaminated by Mycoplasmas by Murine Intraperitoneal
Inoculation
Olivier
Ridoux,
Cédric
Foucault, and
Michel
Drancourt*
Unité des Rickettsies CNRS UPRES-A
6020, Faculté de Médecine, Université de la
Méditerranée, 13385 Marseille Cedex 05, France
Received 9 February 1998/Returned for modification 16 April
1998/Accepted 6 May 1998
 |
ABSTRACT |
Encephalitozoon species are strict intracellular
microsporidia. Cocultures with eukaryotic cell lines can become
accidently contaminated by mycoplasmas. We propose a decontamination
protocol based on differential cell targeting after intraperitoneal
inoculation in mice. Mycoplasma-free microsporidia were isolated from
the brains and spleens of inoculated mice 24 h postinoculation by using
the centrifugation shell vial system. Identification was confirmed by
direct sequencing of PCR-amplified 16S rRNA.
 |
TEXT |
Encephalitozoon cuniculi,
Encephalitozoon hellem, and Encephalitozoon
intestinalis are strict intracellular protozoan parasites responsible for emerging microsporidioses in human immunodeficiency virus-infected patients (14). To date, they have been
isolated from only a few clinical samples by using cultured cell lines (2, 14). Screening of drugs with potential
anti-Encephalitozoon activity has also been based on cell
culture systems (1, 6). Cell cultures can be contaminated by
mycoplasmas (5), and a microsporidial strain can be
contaminated from the first stage of its isolation or during its
propagation, as has been found in our experience. No protocol for
mycoplasma decontamination of microsporidial cultures has been
published. We herein present such a protocol based on exploiting the
differential cell targeting of mycoplasmas and microsporidia after
inoculation in mice.
E. hellem- and E. cuniculi-inoculated Vero cell
CCL-81 (American Type Culture Collection, Rockville, Md.) cultures were
determined to be mycoplasma positive by using a mycoplasma detection
kit (Boehringer, Mannheim, Germany). Twelve 18- to 20-g BALB/c female mice (Charles River, Saint-Aubin lès Elbeuf, France) distributed into three groups were inoculated intraperitonally with 0.5 ml of a
109 E. cuniculi spore suspension (group 1), 0.5 ml of a 109 E. hellem spore suspension (group
2), or 0.5 ml of cell culture medium as a negative control group (group
3); each animal received in addition no less than 106 CFU
of mycoplasma cells per ml. The brains and spleens of the animals were
collected aseptically 3 h postinoculation (p.i.) (two mice per
group) or 24 h p.i. (two mice per group) for direct examination
after Gram-Weber staining (8) and centrifugation at 3,500 rpm (Avanti 30 compact centrifuge; Beckman Instruments, Gagny, France)
for 1 h at room temperature on mycoplasma-free Vero cell cultures
in shell vials. The shell vials were incubated at 37°C under a 5%
CO2 atmosphere, and culture medium was changed weekly.
Identification of microsporidia in tissues and Vero cell cultures was
performed by direct sequencing of PCR-amplified microsporidial 16S
rRNA genes after QIAmp tissue kit (QIAGEN SA, Courtaboeuf, France)
nucleic acid extraction. Consensus primers M1-22
(5'-CACCAGGTTGATTCTGCCTGAC-3') and M331-315
(5'-CAAGTTTCGCGCCTGCT-3') were designed to amplify a 331-bp
region in E. cuniculi (GenBank accession no. L17072) (15), E. hellem (accession no. L19070), and
E. intestinalis (GenBank accession no. U09929). PCR was
performed with a final volume of 50 µl in a Perkin-Elmer 9600 thermocycler, by using the GeneAmp kit (Perkin-Elmer Cetus, Norwalk,
Conn.). An initial denaturation step at 94°C for 10 min was followed
by three cycles consisting of 94°C for 30 s, 40°C for 30 s, and 60°C for 30 s; 35 cycles consisting of 94°C for 30 s, 60°C for 30 s, and 72°C for 30 s; and a final hold at
72°C for 10 min.
Positive and negative controls consisted of E. hellem DNA
and sterile, distilled water, respectively. Amplicons were sequenced in
both directions by using primers M1-22 and M331-315 and the ABI Prism
dRhodamine Dye Terminator Cycle sequencing ready reaction kit
(Perkin-Elmer) after 25 cycles consisting of 95°C for 20 s, 60°C for 10 s, and 60°C for 4 min. Sequencing products
resolved by electrophoresis in a 0.2-mm, 6% polyacrylamide
denaturating gel were recorded with an ABI Prism 377 DNA sequencer
(Applied Biosystems) as described in the protocol of the supplier. Data processed by Sequence Analysis software (Applied Biosystems) were compared to GenBank sequences by using PC software (Intelligenetics).
No clinical difference was noted between negative control and
microsporidium-inoculated mice. Microsporidia were observed in brain
and spleen tissues of inoculated mice 24 but not 3 h p.i. (Fig.
1), and no microsporidia were detected in
the tissue of negative control mice (Table
1). Microsporidia were cultured 6 days
p.i. Amplification of a 331-bp fragment of the microsporidial 16S rRNA
gene was achieved for brain and spleen tissues collected 3 and 24 h p.i. for eight of eight microsporidium-inoculated mice but zero of
four negative controls (Fig. 2).
Sequences of amplified 16S rRNA fragments exhibited 100% similarity
with that deposited in GenBank for the homologous
Encephalitozoon species. Mycoplasmas could not be detected
in Vero cell cultures inoculated with the brains or spleens of mice
over a 6-month period.

View larger version (97K):
[in this window]
[in a new window]
|
FIG. 1.
Gram-Weber staining of the brain (top panel) and the
spleen (bottom panel) collected from a mouse inoculated
intraperitoneally with E. cuniculi for 24 h. Arrows
indicate microsporidia.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Mycoplasma decontamination of E. cuniculi and
E. hellem recovered from brain and spleen tissues from
BALB/c mice
|
|

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 2.
Ethidium bromide-stained agarose gel of a PCR-amplified
microsporidial 16S rRNA gene fragment. Lanes A and J, molecular size
marker V (Boehringer); lane B, sterile distilled water; lane C,
noninoculated mouse brain tissue; lane D, noninoculated mouse spleen
tissue; lane E, E. hellem DNA as positive control; lane F,
E. cuniculi-inoculated mouse brain tissue; lane G, E. cuniculi-inoculated mouse spleen tissue; lane H, E. hellem-inoculated mouse brain tissue; lane I, E. hellem-inoculated mouse spleen tissue. The molecular size in base
pairs is indicated by an arrow to the left of the figure.
|
|
Mycoplasma contamination represents a serious threat to any cell
culture. Its elimination is greatly impeded when coculture represents
the only method of growing an intracellular microorganism. No procedure
was available for the decontamination of microsporidium-inoculated cell
culture, and filtration systems were ineffective in mycoplasma elimination (9). Treatment of contaminated cell lines with a
mycoplasma- removing agent (11), merocyanine 540, Hoechst 33257 (12), or 5-bromouracil (7) is
limited by their potential activity against Encephalitozoon
species. Tetracyclines and fluoroquinolones are effective against
mycoplasmas (9) but also inhibit E. cuniculi. Effective decontamination of Rickettsia-inoculated cell
cultures has been reported after mouse inoculation based on
differential target tissue specificity (3). We hypothesized
that such tissue specificity could be applied to the purification of
contaminated cultures of Encephalitozoon species.
Mycoplasmas are epicellular bacteria associated with epithelium-covered
organs (9). In contrast, Encephalitozoon species
are strict intracellular parasites (13); data from
experimental and natural E. cuniculi infections in mice
(4, 10) indicated perivascular cerebral and splenic granulomas. Clinical observations and observations at the time of
autopsy of AIDS patients with disseminated E. cuniculi
infection produced similar data (14). By using our protocol,
Encephalitozoon strains were detected and cultured in brain
and spleen tissues from inoculated mice 24 h p.i., confirming
systemic infection and intravascular dissemination after
intraperitoneal inoculation. Since laboratory mice may be naturally
infected with E. cuniculi (4), we carefully
checked the absence of microsporidia in negative control mice and
confirmed the identity of microsporidia recovered after mouse
inoculation by molecular characterization.
The centrifugation shell vial technique and direct sequencing of
PCR-amplified 16S rRNA gene proved to be effective and innovative tools
in the recovery and identification of Encephalitozoon
strains. Although a small number of animals were used in this study,
clear-cut results suggest that the use of laboratory animals during the primary isolation of microsporidia from environmental and clinical specimens can prevent contamination. We therefore propose that this
protocol be used in cases of mycoplasma contamination of microsporidium-inoculated cell cultures.
 |
ACKNOWLEDGMENTS |
We thank E. Didier, Tulane University Medical Center,
Covington, La., for kindly providing the E. cuniculi and
E. hellem used in the study.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Unité des
Rickettsies CNRS UPRES-A 6020, Faculté de Médecine,
Université de la Méditerranée, 27, Boulevard Jean
Moulin, 13385 Marseille Cedex 05, France. Phone: (33) 04 91 38 55 17. Fax: (33) 04 91 83 03 90. E-mail:
Didier.Raoult{at}medecine.univ-mrs.fr.
 |
REFERENCES |
| 1.
|
Didier, E. S.
1997.
Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro.
Antimicrob. Agents Chemother.
41:1541-1546[Abstract].
|
| 2.
|
Didier, E. S.,
P. J. Didier,
D. N. Friedberg,
S. M. Stenson,
J. M. Orenstein,
R. W. Yee,
F. O. Tio,
R. M. Davis,
C. Vossbrinck,
N. Millichamp, and J. A. Shadduck.
1991.
Isolation and characterization of a new human microsporidian, Encephalitozoon hellem (n.sp.), from three AIDS patients with keratoconjunctivitis.
J. Infect. Dis.
163:617-621[Medline].
|
| 3.
|
Eremeeva, M. E.,
N. M. Balayeva, and D. Raoult.
1994.
Purification of rickettsial cultures contaminated by mycoplasmas.
Acta Virol.
38:231-233[Medline].
|
| 4.
|
Gannon, J.
1980.
A survey of Encephalitozoon cuniculi in laboratory animal colonies in the United Kingdom.
Lab. Anim.
14:91-94[Abstract/Free Full Text].
|
| 5.
|
Hopps, H. E.,
B. C. Meyer,
M. F. Barile, and R. A. Del Giudice.
1973.
Problems concerning "non-cultivable" mycoplasma contamination in tissue cultures.
Ann. N. Y. Acad. Sci.
225:265-276.
|
| 6.
|
Leitch, G. J.,
M. Scanlon,
A. Shaw,
G. S. Visvesvara, and S. Wallace.
1997.
Use of a fluorescent probe to assess the activities of candidate agents against intracellular forms of Encephalitozoon microsporidia.
Antimicrob. Agents Chemother.
41:337-344[Abstract].
|
| 7.
|
Marcus, M.,
U. Lavi,
A. Nattenberg,
S. Rottem, and O. Markowitz.
1980.
Selective killing of mycoplasmas from contaminated mammalian cells in cell culture.
Nature
285:659-661[Medline].
|
| 8.
|
Moura, H.,
D. A. Schwartz,
F. Bornay-Llinares,
F. C. Sodré,
S. Wallace, and G. S. Visvesvara.
1997.
A new and improved quick-hot Gram chromotrope technique that differentially stains microsporidian spores in clinical samples, including paraffin-embedded tissue sections.
Arch. Pathol. Lab. Med.
121:888-893[Medline].
|
| 9.
|
Razin, S., and E. A. Freundt.
1984.
Order I. Mycoplasmatales Freundt 1955, 71AL, p. 741-787.
In
N. R. Krieg, and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. The Williams & Wilkins Co., Baltimore, Md.
|
| 10.
|
Shadduck, J. A.,
W. T. Watson,
S. P. Pakes, and A. Cali.
1979.
Animal infectivity of Encephalitozoon cuniculi.
J. Parasitol.
65:123-129[Medline].
|
| 11.
|
Spapean, M.,
A. F. Angulo,
P. Marynen, and J. J. Cassiman.
1992.
Detection of bacterial and mycoplasma contamination in cell cultures by polymerase chain reaction.
FEMS Microbiol. Lett.
99:89-94.
|
| 12.
|
Tarshis, M.,
A. Katzenel, and S. Rottem.
1994.
Use of merocyanine 540 and Hoechst 33258 for the selective killing of contaminating mycoplasmas in cell cultures.
J. Immunol. Methods
168:245-252[Medline].
|
| 13.
|
Weber, R.,
R. T. Bryan,
D. A. Schwartz, and R. Owen.
1994.
Human microsporidial infections.
Clin. Microbiol. Rev.
7:426-461[Abstract/Free Full Text].
|
| 14.
|
Weber, R.,
P. Deplazes,
M. Flepp,
A. Mathis,
R. Baumann,
B. Sauer,
H. Kuster, and R. Lüthy.
1997.
Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection.
N. Engl. J. Med.
336:474-478[Free Full Text].
|
| 15.
|
Zhu, X.,
M. Wittner,
H. B. Tanowitz,
A. Cali, and L. M. Weiss.
1993.
Nucleotide sequence of the small ribosomal RNA of Encephalitozoon cuniculi.
Nucleic Acids Res.
21:1315[Free Full Text].
|
Journal of Clinical Microbiology, August 1998, p. 2380-2382, Vol. 36, No. 8
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.